Today

Agents

Chat

Arena

Discover

More

App

Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $615,150 - CYTK News | Rallies

Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $615,150

CYTK•2026-07-14

CEO stock sale and option exercise

Cytokinetics President and CEO Robert I. Blum reported stock sales tied to an option exercise on July 13, 2026.

Disposed of 7,500 shares at USD 82.02.
Exercised options for 7,490 shares at USD 10.6.
Directly held 377,820 shares following the transactions.

Related News

American Financial Group updates financial calendar with quarterly results conference call and webcast

AFG•2026-07-14

US supporting efforts to revive Iraq-Syria crude oil pipeline, US official says

XLE•2026-07-14

Mink Brook Asset Management acquires $22,441 of DLH Holdings common shares

Sources

S

Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $615,150

Sec

DLHC

•

2026-07-14

EDC holds annual shareholder meeting, elects two Class I directors

EDUC•2026-07-14

Envue Medical names Zeev Rotstein board chairman after director resignations

FEED•2026-07-14